Nexthera Capital
1
85M
1
1
- Areas of investment
Summary
The company was established in North America in United States. The main department of described VC is located in the New York.
Among the various public portfolio startups of the fund, we may underline Sutro Biopharma Among the most successful fund investment fields, there are Biotechnology, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
The overall number of key employees were 2.
The typical case for the fund is to invest in rounds with more than 10 participants. Despite the Nexthera Capital, startups are often financed by Skyline Ventures, SV Health Investors, Amgen Ventures. The meaningful sponsors for the fund in investment in the same round are Vida Ventures, Tekla Capital Management, Surveyor Capital.
The top activity for fund was in 2018. The top amount of exits for fund were in 2018. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Biotechnology (1)
- Information Technology (1)
- Medical (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.